NEW YORK, March 21, 2012 (GLOBE NEWSWIRE) -- Synergy Pharmaceuticals, Inc. (Nasdaq:SGYPD) (Nasdaq:SGYPU) (Nasdaq:SGYPW), a developer of new drugs to treat gastrointestinal disorders and diseases, today announced that its President and CEO, Gary S. Jacob, Ph.D, will present at the Maxim Group Growth Conference on Monday, March 26, 2012 at 10:30 a.m. EDT at the Grand Hyatt New York.
